Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Notes have priced
Inv. presentation
LIGAND PHARMACEUTICALS INC (LGND) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/08/2018 BW Ligand Reports First Quarter 2018 Financial Results
04/24/2018 BW Ligand to Report First Quarter 2018 Results on May 8th
03/06/2018 BW Ligand Licenses Glucagon Receptor Antagonist Program to Roivant Sciences
02/21/2018 BW Ligand Reports Fourth Quarter and Full Year 2017 Financial Results
02/05/2018 BW Ligand to Report Fourth Quarter and Full Year 2017 Results on February 21st
11/14/2017 BW Ligand Provides Highlights from Today's Analyst Day Event
11/09/2017 BW Ligand Reports Third Quarter 2017 Financial Results
11/06/2017 BW Reminder: Ligand to Host Analyst Day on November 14th in New York City
10/24/2017 BW Ligand to Report Third Quarter 2017 Results on November 9th
07/20/2017 BW Ligand to Report Second Quarter 2017 Results on August 7th
05/22/2017 BW Ligand to Participate in Two Upcoming Investor Conferences
05/09/2017 BW Ligand Reports First Quarter 2017 Financial Results
04/13/2017 BW Ligand to Report First Quarter 2017 Results on May 9th
03/28/2017 BW Ligand Announces Licensing Partner Janssen Has Filed an IND for an Antibody Discovered Using the OmniAb® Technology
02/28/2017 BW Ligand Provides Highlights from Today's Analyst Day Event
02/23/2017 BW Ligand Reports Fourth Quarter and Full Year 2016 Financial Results
02/13/2017 BW Reminder: Ligand to Host Analyst Day on February 28th in New York City
06/20/2011 BW Ligand Enters into Captisol® Commercial Supply Agreement with Merck
06/06/2011 BW Ligand Presents Multi-Dose Phase I Data on Lead SARM Molecule LGD-4033 at the Endocrine Society Annual Meeting
05/10/2011 BW Ligand Pharmaceuticals Reports First Quarter Results
04/27/2011 BW Ligand to Report First Quarter Results on May 10th
04/20/2011 BW Ligand Partner Prism Pharmaceuticals to be Acquired by Baxter
02/23/2011 BW Ligand to Present at the Citi 2011 Global Healthcare Conference on March 2
02/15/2011 BW Ligand Announces Fourth Quarter and Full Year 2010 Consolidated Financial Results
12/04/2010 BW Ligand Announces Positive Preclinical Data on Small Molecule Erythropoietin Receptor Agonists
12/03/2010 BW Ligand Announces Presentation of Data from Multiple Studies of Dinaciclib by its Partner Merck at the ASH Annual Meeting
11/09/2010 BW Ligand Pharmaceuticals Announces Third Quarter Results
11/02/2010 BW Ligand Announces Approval for Revolade® in Japan
10/29/2010 BW Ligand to Report Third Quarter Results on November 9
10/25/2010 BW Ligand to Present at the Oppenheimer 21st Annual Healthcare Conference on November 2
10/13/2010 BW Ligand Announces Market Launch of Bazedoxifene in Japan and Spain for the Treatment of Postmenopausal Osteoporosis
10/08/2010 BW Ligand Appoints Sunil Patel to Board of Directors
10/07/2010 BW Ligand to Divest Combinatorial Compound Library and Screening Technology for $1.8 Million
09/17/2010 BW Ligand Enters into Agreement with Proximagen for CXCR4 Target
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy